Based on the results of H1 2014, the Representative Office of Farmak in Uzbekistan is ranked among Top 10 largest pharmaceutical manufacturers in the market of the Republic of Uzbekistan.
According to Drug Audit, an analytical and information pharmaceutical database, provided by Yevro Farmis, the Representative Office of Farmak in the Republic of Uzbekistan was ranked 9th, based on the results of H1 2014, with a market share of 2.15% in US dollars.
Farida Akhmetova, Director, Representative Office of Farmak in the Republic of Uzbekistan, says, “Representative Office of Farmak in Uzbekistan was opened 10 years ago, in 2004. The Representative Office was then ranked 24th in the pharmaceutical market with the sales share of 1.16% in money terms. However, even then we set on a target to become ranked among Top-10 pharmaceutical companies in Uzbekistan.
Reaching that target was not easy. Firstly, the market has rather intensive competition (according to Drug Audit, 424 pharmaceutical manufacturers were present in the Uzbekistan pharmaceutical market in Q2 2014). Secondly, activities of our top competitors kept us busy every single moment. However, smooth and professional work of our team allowed the Representative Office of Farmak to climb to No. 9 ranking with 2.15% market share in monetary terms in Q2 2014”.
Nearly 60 Farmak medicinal products in various doses and dosage forms are approved for the today's Uzbekistan pharmaceutical market. The product portfolio of Representative Office of Farmak in Uzbekistan covers diverse therapeutic categories: endocrinology, neurology, cardiology, rheumatology, gastroenterology, ophthalmology products, and products for treatment of cold-related diseases.
According to the decision of economic courts of all instances (2009-2010), the name “Corvalol” (“Corvalolum”) was used exclusively by one manufacturer as the name of the medicinal product. Information that Corvalol was manufactured by 70 pharmaceutical enterprises of the USSR is not true. In the middle of 20th century, Lomonosov Kyiv Chemical and Pharmaceuti...
On October 30 the next court hearing was held in the case regarding the well-known trademark Corvalol Corvalolum. During the court hearing, after having heard the parties’ arguments and a complete and unbiased analysis of the case-file, the Economic Court ruled to dismiss the claim of Pharmaceutical Firm “Darnitsa” against the Ministry of Economic Deve...
Farmak was granted 7 awards in the contest “Best Corporate Media of Ukraine 2019” held by the Association of Corporate Media of Ukraine. The jury consisted of professionals granted the Grand Prix as the highest award to the corporate newspaper “Farmak Life” and the Company’s website. They were awarded with the title “Best Corpmedia Ukraine […]